Daily cannabis use and the digestive tract: An underrecognized relationship

Acta Gastro-Enterologica Belgica

Volumn 73, Issue 3, 2010, Pages 403-405

  Mattens, V ^a   Aerts, M ^a   Mana, F ^a   Urbain, D ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cannabis; Compulsive bathing; Cyclic vomiting syndrome

Indexed keywords

ANTIEMETIC AGENT; CANNABIS; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ANXIETY; ARTICLE; BATH; CANNABIS ADDICTION; CASE REPORT; COMPULSION; DEHYDRATION; HUMAN; MALE; REFLUX ESOPHAGITIS; SMOKING; SMOKING CESSATION; VOMITING;

ADULT; HUMANS; MALE; MARIJUANA ABUSE; VOMITING;

EID: 77958514258     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LOMBARD H.C. Evrose de la digestion, caracterisee par des crises peri-odiques de vomissement et une profonde modification de l'assimilation. Gazette Medicale de Paris, 1861: 312-315.
2. GEE S. On fitful or recurrent vomiting. St. Bart. Hosp. Rep., 1882, 18: 1-6.
3. TACK J., TALLEY N.J., CAMILLERI M., HOLTMANN G., HU P., MALAGELADA J.R., STANGHELLINIV. Functional gastro-duodenal disorders. Gastroenterology, 2006, 130: 1466-79.
4. PRAKASH C., CLOUSE R.E. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants. Am. J. Gastroenterol., 1999, 94: 2855.
5. COMPTON W.M., GRANT B.F., COLLIVER J.D., GLANTZ M.D., STINSON F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA, 2004, 291: 2114-2121.
6. Brodey B.B., McMullin D., Winters K.C., Rosen C.S., Downing D.R., Koble J.M. Adolescent substance use assessment in a primary care setting. Am. J. Drug. Alcohol Abuse, 2007, 33: 447-454.
7. SALLAN S.E., ZINBERG N.E., FREI E. Antiemetic effect of delta-9-tetrahydrocannabitol in patients receiving cancer chemotherapy. N. Engl. J. Med., 1975, 293: 795-7.
8. OSEI-HYIAMAN D., DEPETRILLO M., PACHER P., LIU J., RADAEVA S., BATKAI S., HARVEY-WHITE J., MACKIE K., OFFERTALER L., WANG L., KUNOS G. Endocannabinnoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin. Invest, 2005, 115: 1298-1305.
9. CROCI T., MANARA L., GUAGNINI F.L., AUREGGI G., RINALDI-CARMONA M., MAFFRAND J.P., LE FUR G., MUKENGE S., FERLA G. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br. J. Pharmacol., 1998, 125: 1393-1395.
10. COTA D., MARSICANO G., TSCHOP M., GRUBLER Y., FLACHS-KAMM C., SCHUBERT M., AUER D., YASSOURIDIS A., THÖNE-REINEKE C., ORTMANN S., TOMASSONI F., CERVINO C., NISOLI E., LINTHORST A.C., PASQUALI R., LUTZ B., STALLA G.K., PAGOTTO U. The endogenous cannabinoid affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest., 2003, 112: 423-431.
11. LIU J., GAO B., MIRSHAHI F., SANYAL A.J., KHANOLKAR A.D., MAKRIYANNIS A., KUNOS G. Functional CBA cannabinoid receptors in human vascular endothelial cells. Biochem. J., 2000, 346: 835-840. (Pubitemid 30171048)
12. MUNRO S., THOMAS K.L., ABU-SHAAR M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365: 61-65.
13. KUNOS G., GAO B. Endocannabinoids, CB1 receptors, and liver disease: hitting more than one bird with the same stone. Gastroenterol., 2008, 134: 622-624.
14. HÉZODE C., ROUDOT-THORAVAL N., NGUYEN S., GRENARD P., JULIEN B., ZAFRANI E.S., PAWLOTSKY J.M., DHUMEAUX D., LOTERSZTAJN S., MALLAT A. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatol., 2005, 42: 63-71.
15. HÉZODE C., ZAFRANI E.S., ROUDOT-THORAVAL N., COSTENTIN C., HESSAMI A., BOUVIER-ALIAS M., MEDKOUR F., PAWLOSTKY J.M., LOTERSZTAJN S., MALLAT A. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology, 2008, 134: 432-439.
16. ALLEN J.H., DE MOORE G.M., HEDDLE R., TWARTZ J.C. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gat., 2004, 53: 1566-1570.
17. ROCHE E., FOSTER P.N. Cannabinoid hyperemesis: not just a problem in Adelaide hills. Gut., 2005, 54: 731.
18. MCCALLUM R.W., SOYKAN I., SRIDHAR K.R., RICCI D.A., LANGE R.C., PLANKEY M.W. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment. Pharmacol. Ther, 1999, 13: 77-80.
19. BOECKXSTAENS G.E. Cannabinoid hyperemesis with the unusual symptom of compulsive bathing. Ned. Tijdschr. Geneeskd., 2005, 149: 1468-1471.
20. CHEPYALA P., OLDEN K.W. Cyclic vomiting and compulsive bathing with chronic cannabis use. Clin. Gastroenterol. and Hepatol., 2008, 6: 710-712.
21. WOLFHAGEN F.H. Cannabinoid hyperemesis with the unusual symptom of compulsive bathing. Ned. Tijdschr. Geneeskd., 2005, 149: 1970.